Adipotide/FTTP
Price range: $92.00 through $192.00
Specifications: 2 mg / 5 mg
Ingredient: Adipotide
Dosage Form: Lyophilized Powder
SKU:
Description
Adipotide, also known as FTTP (Fat-Targeted Pro-Apoptotic Peptide), is an experimental peptidomimetic designed to induce weight loss by specifically targeting the blood supply of white adipose tissue. Unlike conventional anti-obesity drugs that suppress appetite via central nervous system pathways, Adipotide adopts a targeted anti-angiogenic strategy.
It consists of a homing domain and a pro-apoptotic domain. The homing domain binds to receptors specifically expressed on blood vessels of adipocytes, while the pro-apoptotic domain triggers programmed cell death (apoptosis) in vascular endothelial cells. By selectively disrupting the vascular structure of fat deposits, Adipotide leads to adipocyte atrophy and subsequent resorption by the body.
With this mechanism, Adipotide stands out as a distinctive research tool in obesity studies. It is particularly effective against stubborn visceral fat, which is generally resistant to diet and exercise. Studies have demonstrated that Adipotide rapidly reduces body fat and markedly improves insulin sensitivity by physically diminishing adipose tissue volume, rather than merely regulating calorie intake. Acting directly on the supporting vasculature of fat tissue, it possesses unique metabolic properties.
Currently, Adipotide remains a key compound for scientific research covering adipose tissue biology, metabolic syndrome, and targeted vascular therapies for the treatment of severe obesity and its associated complications.
Shipping and Delivery
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
